These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12142632)

  • 1. Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments.
    Takahashi M; Echizen H; Takahashi K; Shimada S; Aoyama N; Izumi T
    Ther Drug Monit; 2002 Aug; 24(4):492-6. PubMed ID: 12142632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of acute cibenzoline intoxication in a hemodialysis patient].
    Ozasa Y; Takamura S; Seishi I; Kitada H; Uekihara S; Hayano S
    Chudoku Kenkyu; 2003 Jul; 16(3):335-8. PubMed ID: 14582357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renal impairment on the pharmacokinetics of cibenzoline.
    Massarella JW; Khoo KC; Aogaichi K; Di Persio D; Smith M; Kluger J; Chow MS
    Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of charcoal hemoperfusion on clearance of cibenzoline succinate (cifenline) poisoning.
    Aoyama N; Sasaki T; Yoshida M; Suzuki K; Matsuyama K; Aizaki T; Izumi T; Kondo R; Kamijo Y; Soma K; Ohwada T
    J Toxicol Clin Toxicol; 1999; 37(4):505-8. PubMed ID: 10465249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cibenzoline in patients with renal impairment.
    Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A
    J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure elevates serum levels of cibenzoline in arrhythmic patients.
    Kotake T; Takada M; Komamura K; Kamakura S; Miyatake K; Kitakaze M; Morishita H
    Circ J; 2006 May; 70(5):588-92. PubMed ID: 16636495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral cibenzoline in arrhythmia patients.
    Brazzell RK; Colburn WA; Aogaichi K; Szuna AJ; Somberg JC; Carliner N; Heger J; Morganroth J; Winkle RA; Block P
    Clin Pharmacokinet; 1985; 10(2):178-86. PubMed ID: 3995859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics and dose proportionality of oral cibenzoline.
    Khoo KC; Szuna AJ; Colburn WA; Aogaichi K; Morganroth J; Brazzell RK
    J Clin Pharmacol; 1984 Jul; 24(7):283-8. PubMed ID: 6480874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
    Honda T; Soejima H; Honda T
    Jpn Circ J; 2000 Jan; 64(1):72-5. PubMed ID: 10651210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
    Khoo KC; Givens SV; Parsonnet M; Massarella JW
    J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cibenzoline intoxication necessitating implantation of a biventricular assist system in a patient with severe cardiomyopathy.
    Ohata T; Ueda H; Yamada Y
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):95-7. PubMed ID: 20421279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fatal voluntary poisoning with cibenzoline. Failure of conventional therapies].
    Viallon A; Page Y; Lafond P; Venet C; Tardy B; Zeni F; Bertrand JC
    Presse Med; 1998 Oct; 27(32):1621-5. PubMed ID: 9819600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of myasthenia-like symptoms induced by cibenzoline overdosage].
    Nakagawa Y; Ishizaki M; Kozono A; Hanada K; Higashi T; Ueyama H
    Rinsho Shinkeigaku; 2018 Jan; 58(1):41-44. PubMed ID: 29269691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.